Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection.

BMC complementary and alternative medicine - 29 Jun 2012

Schunter Marco, Chu Hiutung, Hayes Timothy L, McConnell Delandy, Crawford Sean S, Luciw Paul A, Bengmark Stig, Asmuth David M, Brown Jennifer, Bevins Charles L, Shacklett Barbara L, Critchfield J William

Abstract excerpt

BACKGROUND: Infection with HIV-1 results in marked immunologic insults and structural damage to the intestinal mucosa, including compromised barrier function. While the development of highly active antiretroviral therapy (HAART) has been a major advancement in the treatment of HIV-1 infection, th...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ADP-ribosyl Cyclase 1
Share to C-Reactive Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dietary Fiber

Share to Fermentation

Share to Lipopolysaccharide Receptors

Share to Probiotics

Share to Programmed Cell Death 1 Receptor

Source

Open in PubMed Open full text

Identifiers

PMID: 22747752
DOI: 10.1186/1472-6882-12-84
PMCID: PMC3414771

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22747752-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection.PMID 22747752Read ↗

Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trialSemantic proximity Read ↗

SynbioticLactobacillus acidophilusNCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: a randomized, double-blinded cross-over trialSemantic proximity Read ↗

Microbiota Modulation to Reduce Cardiovascular Risk in HIV Patients: A Systematic ReviewSemantic proximity Read ↗

Probiotic Supplementation Reduces Inflammatory Profiles But Does Not Prevent Oral Immune Perturbations During SIV InfectionSemantic proximity Read ↗

Effects of synbiotic supplementation on gut microbiome, serum level of TNF-α, and expression of microRNA-126 and microRNA-146a in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomized clinical trialSemantic proximity Read ↗

AG1®, a Novel Synbiotic, Maintains Gut Barrier Function following Inflammatory Challenge in a Caco-2/THP1-Blue™ Co-Culture ModelSemantic proximity Read ↗

Exploring the gut microbiome: probiotics, prebiotics, synbiotics, and postbiotics as key players in human health and disease improvementSemantic proximity Read ↗

Probiotics, Prebiotics, and Synbiotics: Gut and BeyondSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.